Picture of Surrozen logo

SRZN Surrozen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Surrozen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-24.4-32.7-54.6-36-43
Depreciation
Non-Cash Items1.451.633.99-1.684.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.4280.052-0.221-8.42-3.93
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-21.1-29.1-48.8-44.1-40.4
Capital Expenditures-1.56-0.874-1.27-0.728-0.398
Purchase of Fixed Assets
Other Investing Cash Flow Items0-14.2-76.43952.1
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-1.56-15.1-77.738.351.7
Financing Cash Flow Items-0.004
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities28.950.1125-2.560.276
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.295.88-1.89-8.411.6